Paris, France
Joined February 2016
21
🎉 Exciting News! 🎉 SafeHeal® recently closed an oversubscribed €35 million Series C equity financing, led by Solar Eclipse with new investors Gideon Strategic Partners and M&L Healthcare (part of M&L Group), and continued support from Sofinnova Partners and a leading multinational life sciences corporation. This capital infusion leaves SafeHeal® well-funded to complete its IDE Pivotal study and accelerate preparation for the commercial launch of our lead technology, Colovac®. A huge thank-you to our investors and the entire SafeHeal team for supporting our mission to drive innovation in colorectal surgery. 🙌 🔗 Read the full press release here: loom.ly/s3wdeZg Colovac® is an Investigational Device, Limited by Federal (or United States) Law to Investigational Use. #MedTech #ColorectalCancer #ColorectalCare #OstomyAlternatives #SafeHeal
1
1
48
We’re proud to announce the successful completion of enrollment in our Standard of Care (SH-SOC23) arm, the first phase of our two-part study in rectal cancer surgery! 🚀 🔜 Next Up: Once IDE approval is obtained, SafeHeal will initiate the SAFE-3CV study, which will evaluate the safety and effectiveness of Colovac®, our innovative endoluminal bypass device. 🙏 Thank you to our dedicated clinical investigators and the patients who participated. You’ve brought us one step closer to a future where patients may enjoy a better quality of life by reducing the burden of a temporary stoma and its associated complications and faster return to normal function. Colovac is an Investigational Device, Limited by Federal (or United States) Law to Investigational Use
41
Busy Month at Lankenau Hospital w/ Dr. John Marks! Dr. Marks enrolled 3 patients this month in the @safeheal SOC23 study which will provide robust Standard-of-Care Control data to which a future stoma alternative can be compared.
1
71
Currently enrolling at several sites throughout the US/ EU. Visit Safeheal.com to learn more about our study, sites and what we are doing to lessen the burden of #rectalcancer patients requiring a temporary ostomy.
35
Welcome @davidjhiller and his team @NovantHealth to the SafeHeal SOC trial. If you or someone you know must undergo #rectalcancer surgery w/diverting ostomy please reach out him to see if you are eligible for our clinical trial. Visit safeheal.com for information
1
3
97
A Big Welcome to the latest site to be activated for our SafeHeal SOC23 Study: Lankenau Hospital .
67
We're excited to announce our 2016 Finalists: @dynamicbrace @cataliahealth @safeheal & @mitcheggers1 Congratulations! See you at #AdvaMed16
1
5
1
10
Congratulations to the @MedTechAwards 2016 finalists @dynamicbrace @safeheal @cataliahealth and Adient Medical! Can't wait for @AdvaMedConf xitter.cf/AdvaMedConf/status/780…
Announcing our #MedTechInnovator finalists: Adient Medical, @CataliaHealth, Green Sun Medical @dynamicbrace & Safe Heal Medical. #AdvaMed16
SafeHeal is a proud finalist of the MedTech Innovator at AdvaMed 2016 ! @advamedconf @medtechawards @safeheal
2
#safeheal Avoid the delibitation of ostomies and the need for the ostomy takedown surgery - a huge win for patients ! #medtechinnovator
2
3
A8 : not really if you're providing a disruptive approach / product... but people might shy away due to the risk profile #MedTechInnovator
A6 : EU notified bodies are extremely late in delivering their reports due to excessive workload after the CE mark changes #MedTechInnovator
1
A4 : Derisk your regulatory pathway early in your development, with CE clinical pathway review with NB and FDA pre-sub #MedTechInnovator
@tueohealth ... and medtech investors do not understand digital health either ;-) #MedTechInnovator
1
1
The milestone needed to raise Series A capital seems to have shifted to proof-of-concept to first-in-man for many VCs... #MedTechInnovator
2